Home Subscription Services
 
   

 
Journal of Oral & Facial Pain and Headache
OFPH Home Page
About the Editor
Editorial Board
Accepted Manuscripts
Submit
Author Guidelines
Submission Form
Reprints / Articles
Permissions
Advertising
MEDLINE Search
 
 
 
 
 
FacebookTwitterYouTube
Quintessence Publishing: Journals: OFPH
Journal of Oral & Facial Pain and Headache

Edited by Barry J. Sessle, BDS, MDS, BSc, PhD, FRSC

Official Journal of the American Academy of Orofacial Pain,
the European, Asian, and Ibero-Latin Academies of Craniomandibular
Disorders, and the Australian Academy of Orofacial Pain

ISSN 2333-0384 (print) • ISSN 2333-0376 (online)

Publication:
Fall 2010
Volume 24 , Issue 4

Back
Share Abstract:

Effects of Low-dose Intramuscular Ketorolac on Experimental Pain in the Masseter Muscle of Healthy Women

Karina H. Bendixen, DDS/Lene Baad-Hansen, DDS, PhD/Brian E. Cairns, PhD, RPh/Peter Svensson, DDS, PhD, Dr Odont

Pages: 398407
PMID: 21197512

Aims: To investigate the effect of a low dose of intramuscular (im) ketorolac compared with lidocaine (LA) in a double-blinded, randomized, and controlled trial. Methods: Twelve healthy women participated in three sessions and received two injections into their right masseter muscle per session. The first injections contained hypertonic saline (HS, 5% in 0.2 mL) to induce muscle pain. The second injections were given 30 minutes later and contained, together with HS, either ketorolac (3 mg in 0.2 mL), LA (2% lidocaine in 0.2 ml), or HS alone (control). HS-evoked pain intensity was scored on a 0 to 10 electronic visual analog scale (VAS) measuring peak, duration, and area under the curve (AUC). Pressure pain thresholds (PPT), pressure pain tolerance levels (PPTOL), and pain on palpation (POP) were determined bilaterally on the masseter muscle before and 5, 15, and 25 minutes after the injections. Maximum jaw opening (MJO) was measured at baseline and every 10 minutes after. McGill Pain Questionnaire (MPQ) scores and the extent of the HS-evoked pain (pain drawings) were recorded at baseline, 2 minutes after the first and second injections, and every 10 minutes during the entire experimental session. Results: There were no differences between the three sessions in HS-evoked pain measures from the first injection (P > .05). During the second injection, HS + LA demonstrated significantly lower VAS peak, duration, and AUC scores than control and HS + ketorolac (P < .001). In the HS + ketorolac session, the VAS AUC was significantly lower than in the control session (P < .005). The sessions had no main effect on PPT, PPTOL, POP, MJO, or pain drawings (P > .05). Conclusion: A low dose of im ketorolac has a significant and immediate analgesic effect on HS-evoked jaw muscle pain but significantly less than LA. A local anesthetic-like effect may be the underlying mechanism. J OROFAC PAIN 2010;24:398407

Key words: experimental muscle pain, ketorolac, local anesthetics, NSAIDs, trigeminal nociception

Full Text PDF File | Order Article

 

 
Get Adobe Reader
Adobe Acrobat Reader is required to view PDF files. This is a free program available from the Adobe web site.
Follow the download directions on the Adobe web site to get your copy of Adobe Acrobat Reader.
  © 2014 Quintessence Publishing Co Inc
 

Home | Subscription Services | Books | Journals | Multimedia | Events | Blog
Terms of Use | Privacy Policy | About Us | Contact Us | Advertising | Help | Sitemap | Catalog